The Gist Healthcare Podcast

Moderate House Republicans are pushing for action on expiring Affordable Care Act tax credits. Trust in health institutions is waning, with a new poll indicating rising skepticism towards agencies like the CDC and FDA. Meanwhile, Donald Trump and Health Secretary Robert F. Kennedy Jr. are perceived to be impacting public health negatively. In exciting news, DocGo plans to acquire SteadyMD to enhance telehealth services, and Walmart is set to sell Abbott's Lingo glucose monitor, tapping into the booming biowearables market.

Rising costs for the 2026 ACA exchange are causing sticker shock among consumers. California is set to launch a plan for affordable insulin, aiming to sell it for $45. Meanwhile, Prospect Medical Holdings is in the spotlight with ongoing hospital sales amidst a bankruptcy crisis. Amazon Pharmacy is innovating by introducing prescription kiosks at One Medical Clinics. Lastly, a new poll reveals waning public trust in political figures, including President Trump and HHS Secretary Kennedy Jr.

Lizzy Lawrence, a reporter for STAT News focusing on the FDA, sheds light on the long-standing exclusion of pregnant women from clinical drug trials. She discusses how the thalidomide crisis shaped current research practices, leading to significant knowledge gaps. Lawrence addresses the overreaction to past risks, highlighting the need for better data on commonly used medications like Tylenol. She also explores recent federal recommendations aimed at reintegrating pregnant individuals into trials and the ethical implications of this necessary change.

A multibillion-dollar acquisition in the healthcare industry is on the horizon as Qualtrics plans to buy Press Ganey Forsta. Meanwhile, public trust in the CDC is at a record low, raising concerns about agency effectiveness. A shocking report reveals that Medicare has spent nearly $2 billion on unnecessary back surgeries over three years, highlighting regional disparities in surgical practices. Plus, an intriguing preview on the implications of excluding pregnant women from clinical drug trials adds to the conversation.

In an intriguing discussion, the potential impact of a government shutdown on healthcare funding is explored, with contrasting views from political leaders. President Trump hints at possible negotiations on ACA subsidies, while experts warn of skyrocketing premiums if enhancements expire. The acquisition of Summa Health by General Catalyst's HATCo raises questions about the shift to for-profit care and necessary community commitments. Additionally, the CDC updates vaccine recommendations, emphasizing individual decision-making for COVID shots and new guidelines for childhood vaccinations.

Unpack the tense political drama around extending Affordable Care Act tax credits as lawmakers scramble to avert a shutdown. Discover how a new agreement between the Trump administration and Pfizer aims to cut drug prices for Americans. Dive into the competitive landscape of AI in healthcare, where lawsuits are flying over alleged code theft and market strategies. A mix of policy, pricing, and tech rivalry makes for a riveting discussion!

A proposed $100,000 fee for H-1B work visas may exacerbate physician shortages in healthcare. Meanwhile, the CMS pilot introducing AI-driven prior authorizations is facing criticism from Congress. Exciting news comes from Medline, hinting at a potential $50 billion IPO next month. Additionally, UnitedHealthcare has launched a new marketplace for members to purchase wellness and chronic care benefits. Stay tuned for these impactful developments!

The CDC's top vaccine panel is gearing up for crucial votes, shifting from universal COVID-19 recommendations to tailored discussions between providers and patients. Privia Health is making waves by acquiring Evolent's ACO business, expanding its value-based care model. Meanwhile, a GAO report sheds light on the troubling trend of urban hospital closures and the significant community impact, leaving many without essential emergency services. As the healthcare landscape shifts, listeners will want to stay tuned for more insights!

The discussion highlights a controversial claim linking prenatal Tylenol use to autism and ADHD, sparking debate among medical professionals. We also dive into Omnicare's recent bankruptcy filing, revealing the financial repercussions of a False Claims Act verdict. In Texas, VillageMD's sale of clinics raises questions about healthcare access amid Walgreens' ownership changes. Lastly, a teaser hints at an upcoming report on urban hospital closures and their connection to rising costs and aging facilities.

Dr. Sylvia Owusu-Ansah, an associate professor of pediatrics and emergency medicine, shares her journey as a medical consultant for the acclaimed HBO Max series The Pitt. She discusses her surprising first encounters with Noah Wyle and the show's writers, emphasizing her contributions to storylines about the sickle cell pain crisis and its reflection of racial disparities in emergency care. Dr. Owusu-Ansah highlights how the show's structure captures the essence of a real emergency department, bringing clinical realism to the screen.